What is Ozempic?
Ozempic is a brand-name prescription medication manufactured by Novo Nordisk. Its active ingredient is semaglutide, a GLP-1 receptor agonist administered as a once-weekly subcutaneous injection.
Ozempic is FDA-approved for two indications: improving blood sugar control in adults with type 2 diabetes, and reducing the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
⚠️ Note: Ozempic is not FDA-approved for weight loss. Wegovy (semaglutide 2.4mg) is the FDA-approved version for chronic weight management. Ozempic is frequently prescribed off-label for weight loss.
How Ozempic Works
Ozempic mimics GLP-1, a hormone naturally released in your gut after eating. It works through several mechanisms simultaneously:
- Stimulates insulin secretion — only when blood glucose is elevated, reducing hypoglycemia risk
- Suppresses glucagon — reduces the liver's glucose output between meals
- Slows gastric emptying — food stays in your stomach longer, promoting fullness
- Acts on brain appetite centers — reduces hunger signals in the hypothalamus
- Reduces liver glucose production — improves overall glycemic control
💡 The appetite-suppressing effects occur at the brain level, not just the stomach. This is why many people describe Ozempic as "quieting food noise" — the constant mental preoccupation with food diminishes significantly.
Ozempic Dosing Schedule
| Phase | Dose | Duration | Pen |
|---|---|---|---|
| Initiation | 0.25 mg/week | Weeks 1–4 | 0.25/0.5mg pen |
| Maintenance 1 | 0.5 mg/week | Weeks 5–8+ | 0.25/0.5mg pen |
| Escalation | 1 mg/week | Weeks 9–12+ | 1mg pen |
| Max dose | 2 mg/week | Week 13+ | 2mg pen |
Injection Tips
- Inject on the same day each week — set a recurring reminder
- Rotate between abdomen, thigh, and upper arm injection sites
- Store unused pens in the refrigerator (2–8°C); in-use pens can stay at room temp for 56 days
- Allow the pen to reach room temperature for 30 minutes before injecting
💡 Use our Dose Schedule Calculator to generate a personalized week-by-week schedule.
Weight Loss Results
| Trial | Dose | Duration | Avg Weight Loss |
|---|---|---|---|
| SUSTAIN 1–5 | 0.5–1mg | 30 weeks | 4–6% |
| SUSTAIN-FORTE | 2mg | 40 weeks | ~9–11% |
| STEP 1 (Wegovy dose) | 2.4mg | 68 weeks | 14.9% |
⚠️ About 1 in 8 people are non-responders to GLP-1 medications. If you haven't lost at least 5% of body weight after 16 weeks at a therapeutic dose, discuss alternatives with your doctor.
Week-by-Week Results Timeline
Weeks 1–4 · 0.25mg
Initiation Phase
Reduced appetite begins. Some nausea as your body adjusts. Minimal weight change — this dose is for tolerance, not effect.
Weeks 5–8 · 0.5mg
First Results
Appetite suppression becomes noticeable. Most people lose 2–4 lbs. "Food noise" begins to quiet.
Weeks 9–16 · 1mg
Accelerating Loss
Weight loss accelerates. Average 0.5–1 lb/week. Energy levels often improve. Nausea typically subsides.
Weeks 17–32 · 1–2mg
Steady Progress
Consistent weekly losses. Many reach 8–10% total body weight loss by week 32.
Weeks 32+ · Maintenance
Plateau & Maintenance
Weight loss slows as body adapts. Focus shifts to maintenance strategies. See our Plateau Calculator.
Side Effects
Common (10–40% of users)
- Nausea — most common, especially in first 4–8 weeks
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain or discomfort
🚨 Seek immediate medical attention for: severe abdominal pain (possible pancreatitis), vision changes, rapid heart rate, signs of allergic reaction, or neck lump/hoarseness (possible thyroid tumor).
Contraindications
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Pregnancy or breastfeeding
Cost & Insurance
| Coverage Type | Monthly Cost | Notes |
|---|---|---|
| Without insurance | ~$935 | List price |
| With commercial insurance (diabetes) | $25–$150 | If covered for diabetes |
| Novo Nordisk savings card | As low as $25 | Eligible commercially insured patients |
| Medicare/Medicaid | Varies widely | Coverage depends on plan — Medicare Advantage may cover at $0 |
💡 Use our Cost Calculator and Insurance Guide to estimate your out-of-pocket costs and explore all savings options.
Ozempic vs. Wegovy
| Feature | Ozempic | Wegovy |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Max approved dose | 2 mg/week | 2.4 mg/week |
| FDA indication | Type 2 diabetes, CV risk | Chronic weight management |
| Avg weight loss | ~8–11% | ~15% |